SARomics Biostructures – Structural Biology Contract Services

SARomics Biostructures is a leading structural biology and drug discovery CRO based in Medicon Village, Lund, Sweden. It specializes in providing advance structural biology and integrated drug discovery outsourcing services.

Integrated Structural Biology & Drug Discovery CRO

SARomics Biostructures, a structural biology and drug discovery services CRO company based in Medicon Village, Lund, Sweden, is a leading provider of structural biology and drug discovery outsourcing services. Our comprehensive services encompass:

Furthermore, we proudly present the proprietary Weak Affinity Chromatography (WAC™) technology and crystallographic fragment screening services for fragment screening and fragment-based drug design. Our WAC services are jointly owned by our company with our partner RG Discovery. The details of our technology platform can be found on our platform overview page. You may also view the specifics of our protein crystallization and structure determination services workflow.

What are our customers saying about our company services?

A recent customer survey (October 2023) showed that more than 90% of our customers are happy or very happy with our company’s structural biology and drug discovery services and are ready to recommend us to others. More than 50% answered that they contacted us after a recommendation from a colleague. Among the comments we received:
Excellent team, awesome science, and always a pleasure to work with! The team is very communicative and always available for 1:1 discussions.

Highly flexible in terms of project structures, pricing, and delivery. I always highly recommend SARomics, and they are my preferred CRO of all the partners we regularly use.

“Fantastic collaboration, very professional and easy to discuss with, always proactive and flexible. Thank you!”

“Very satisfied with all phases of the project from initiation to delivery. Very professional company”.

“SARomics has been a good partner. We appreciate working with you”.

See also our blog post on the advantages of outsourcing early drug discovery services to a CRO.


Watch the company presentation by Björn Walse, the CEO of SARomics Biostructures.

The presentation of our structural biology and drug discovery platform took place during a virtual meeting jointly organized by SciLifeLab Sweden and the MAX IV BioMax beamline. The webinar focused on “Drug discovery & development opportunities for industry at SciLifeLab and MAX IV.” The total duration is about 14 minutes.